Franz-Josef Mais

USPTO Granted Patents = 41 (Patent Applications = 5)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 9 (Patent Applications = 17)

Average Co-Inventor Count = 3.0

ph-index = 8

Forward Citations = 238(Granted Patents)

Location History:

Düsseldorf, DE (2001 - 2019)
Dusseldorf, DE (1992 - 2020)
Duesseldorf, DE (1989 - 2021)

Company Filing History:

29 out of 12,157

Bayer Aktiengesellschaft

Bayer Intellectual Property Gmbh

patents

4. 2 out of 378

Bayer Pharma Aktiengesellschaft

patents

5. 1 out of 1

Bayer Akitnegesellschaft

patent

Years Active: 1989-2021

Loading Chart...

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11203593 - Forms of methyl {4,6-diamino-2-[1(2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate (2021-12-21),

2. 10662188 - Forms of methyl {4,6-diamino-2-[1 (2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl} methyl carbamate (2020-05-26),

3. 10570130 - Process for preparing methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compound (2020-02-25),

4. 10494372 - Synthesis of copanlisib and its dihydrochloride salt (2019-12-03),

5. 10351562 - Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-B]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compound (2019-07-16),

6. 10087183 - Forms of methyl {4,6-diamino-2-[1 (2-fluorobenzyl)-1h-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate (2018-10-02),

7. 10030014 - Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compound (2018-07-24),

8. 9388177 - Method for preparing substituted triazolopyridines (2016-07-12),

9. 8853398 - Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b] pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compound (2014-10-07),

10. 8501945 - Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate and its purification for use as pharmaceutically active compound (2013-08-06),

11. 8492544 - Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-B]pyridin-3-yl]pyrimidin-5-yl}Methylcarbamate and its purification for use as pharmaceutically active compound (2013-07-23),

12. 6822095 - Method for producing 4,6-dichloropyrimidine (2004-11-23),

13. 6706934 - Method for producing 2,3,4,5-tetrachlorobenzotrifluoride (2004-03-16),

14. 6562970 - Method for producing 4-chloro-6-hydroxypyrimidine (2003-05-13),

15. 6525198 - Method for producing 4,6-dichloropyrimidine with sulfur compounds and phosphorus compounds (2003-02-25),

Title: Inspiring Innovation: The Inventor Franz-Josef Mais

Introduction:

Inventor Franz-Josef Mais, hailing from Düsseldorf, Germany, is a shining example of how innovation and persistence can lead to groundbreaking solutions for complex problems. His dedication to creating impactful inventions serves as a beacon for aspiring inventors worldwide.

Latest Patents:

Franz-Josef Mais has been granted an impressive total of 41 patents, with his latest contributions focusing on revolutionary forms of methyl {4,6-diamino-2-[1(2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate. These inventions include Modification I, Modification II, mono-DMSO solvate, sesqui-DMSO solvate, and β-ethyl acetate solvate, showcasing his expertise in the pharmaceutical field.

Career Highlights:

During his illustrious career, Franz-Josef Mais has made significant strides in the pharmaceutical industry, making notable contributions to renowned companies such as Bayer Aktiengesellschaft and Adverio Pharma GmbH. His dedication to innovation has led to the development of groundbreaking solutions that have the potential to impact the lives of many.

Collaborations:

Throughout his journey, Franz-Josef Mais has collaborated with esteemed colleagues such as Helmut Fiege and Alexander Klausener, pooling their expertise to push the boundaries of invention and research. These collaborations have led to the creation of patented technologies that have garnered international recognition.

Conclusion:

Inventor Franz-Josef Mais stands as a testament to the power of innovation and perseverance, with a remarkable portfolio of patents that highlight his ingenuity and dedication to creating transformative solutions. His enduring legacy continues to inspire the next generation of inventors and innovators, shaping the landscape of the pharmaceutical industry and beyond.

This text is generated by artificial intelligence and may not be accurate.